Physician profile
John B Minnoch
NPI 1326083437
$1,602.44
in general payments reported to CMS, 2019-2025
8 companies · $785 in 2025
The $785 reported for 2025 was more than what 94% of Dentist providers received nationally (typical 2025 total: $70.27).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $23.22 · 2020: $140 · 2021: $154 · 2022: $23.33 · 2023: $253 · 2024: $224 · 2025: $785.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Gift: $996 · Consulting Fee: $200 · Food and Beverage: $67.16.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Gift | $995.50 |
| Consulting Fee | $200.00 |
| Food and Beverage | $67.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ultradent Products INC | $1,006.77 | 2023-2025 | Opalescence |
| Dentsply LLC | $200.00 | 2024 | |
| Dentsply Sirona INC | $157.27 | 2020-2023 | Suresmile, Imaging Software |
| Align Technology, INC. | $95.10 | 2021 | |
| Straumann USA LLC | $72.45 | 2020-2021 | |
| Orapharma, A Division of Bausch Health US, LLC | $24.30 | 2024 | Ossix Plus, Arestin |
| Patterson Companies, INC. | $23.33 | 2022 | |
| Zimmer Biomet Holdings, INC. | $23.22 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Minnoch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.